Skip to main content
. 2023 Jun 6;11(6):1069. doi: 10.3390/vaccines11061069

Table 1.

Sociodemographic characteristics of the study population (N = 805).

n %
Sex
Female 428 53.1
Male 377 46.9
Age
18–24 100 12.4
25–34 153 19.0
35–49 195 24.3
50–64 231 28.7
65 and more 126 15.7
Education
Primary 29 3.6
Vocational 59 7.3
Secondary 411 51.1
Tertiary 306 38.0
Place of living
Rural area 323 40.1
City < 20 k 94 11.7
City 20–99 k 154 19.1
City 100–199 k 66 8.2
City 200–499 k 73 9.0
City > 500 k 95 11.8